Cargando…
The quality-adjusted life-years in the oncological patients’ health-related quality of life
The oncological treatment can significantly affect patients’ health-related quality of life (HRQoL), which should be monitored to ensure our patients’ well-being. The often-used HRQoL measurer is the quality-adjusted life-year (QALY) indicator of the disease burden, describing both quality and quant...
Autores principales: | Kucnerowicz, Karolina, Pietrzak, Agata, Cholewiński, Witold, Martenka, Piotr, Marszałek, Andrzej, Burchardt, Ewa, Strzesak, Erwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363419/ https://www.ncbi.nlm.nih.gov/pubmed/35945241 http://dx.doi.org/10.1038/s41598-022-17942-1 |
Ejemplares similares
-
Author Correction: The quality-adjusted life-years in the oncological patients’ health-related quality of life
por: Kucnerowicz, Karolina, et al.
Publicado: (2022) -
Detection of clinically silent brain lesions in [18F]FDG PET/CT study in oncological patients: analysis of over 10,000 studies
por: Pietrzak, Agata, et al.
Publicado: (2021) -
Initial and Delayed Metabolic Activity of Palatine Tonsils Measured with the PET/CT-Dedicated Parameters
por: Pietrzak, Agata, et al.
Publicado: (2020) -
Sequential delayed [18 F]FDG PET/CT examinations in the pharynx
por: Pietrzak, Agata Karolina, et al.
Publicado: (2020) -
Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [(18)F]FDG PET/CT Study Protocol—10 Years of Single-Institutional Experiences
por: Pietrzak, Agata, et al.
Publicado: (2021)